Gastric Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2005; 11(21): 3234-3239
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3234
Table 1 Sequence and co-ordinate of primers and probes for RT-PCR analysis.
TranscriptOligonucleotide sequence (5’-3’)Product size (bp)Genome coordinate
EBNA15’ primerGATGAGCGTTTGGGAGAGCTGATTCTGCA27367510-67539
3’ primerTCCTCGTCCATGGTTATCAC108075-108056
probeAGACCTGGGAGCAGATTCAC67608-67627
EBNA25’ primerGCTGCTACGCATTAGAGACC33947892-47911
3’ primerTCCTGGTAGGGATTCGAGGG48616-48597
probeCAGCACTGGCGTGTGACGTGGTGTAAGTT48391-48420
LMP15’ primerTCCTCCTCTTGGCGCTACTG490169383-169364
3’ primerTCATCACTGTGTCGTTGTCC168740-168759
probeGAACAGCACAATTCCAAGGAACAATGCCTG169061-169090
BZLF15’ primerATTGCACCTTGCCGCCACCTTTG608103194-103180
3’ primerCGGCATTTTCTGGAAGCCACCCGA102486-102463
probeCACTGCTGCTGCTGTTTGAACAGT102772-102795
BARF15’ primerGGCTGTCACCGCTTTCTTGG203165560-165579
3’ primerAGGTGTTGGCACTTCTGTGG165762-165743
probeCTGGTTTAAACTGGGCCCAGGAGAGGAGCA165644-165673
BHRF15’ primerGTCAAGGTTTCGTCTGTGTG21153830-53849
3’ primerTTCTCTTGCTGCTAGCTCCA54480-54461
probeATGCACACGACTGTCCCGTATACAC54435-54411
Table 2 Comparison of clinicopathological data between EBVaGC and EBVnGC patients.
EBVaGC (n = 13)EBVnGC (n = 45)P
Age (yr) (mean±SD)159.76±10.1757.31±14.050.5613 (t = 0.5844)
Sex
Male13350.1466 (χ2 = 2.1070)
Female010
Tumor location
Cardia/body9210.1516 (χ2 = 2.0566)
Antrum424
Histological subtype
Adenocarcinoma12410.6704 (χ2 = 0.1811)
Signet ring carcinoma14
Tumor differentiation
Moderate170.7890 (χ2 = 0.0716)
Poor1238
Lymph node metastasis
Present10330.9999 (χ2 = 0.0098)
Absent312
Tumor stage2
Early011.0000
Advanced1344
Table 3 Apoptotic index and ki-67 index in EBVaGC and EBVnGC (mean±SD).
AIKI
EBVaGCs (n = 13)0.97±0.41128.25±6.282
EBVnGCs (n = 45)2.03±0.6037.86±14.52
Table 4 bcl-2 and p53 expression in EBVaGC and EBVnGC.
nbcl-2
p53 expression
p53 overexpression
+-+-+-
EBVaGC1376112211
EBVnGC4522233962619
χ20.09910.07167.2593
P value0.75290.79120.0085